Ascendis Health (ASC) Stock Overview
A health and wellness company, provides health and wellness products and clinical and diagnostic medical devices in South Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ASC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Ascendis Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R0.92 |
| 52 Week High | R1.13 |
| 52 Week Low | R0.72 |
| Beta | 0.20 |
| 1 Month Change | 0% |
| 3 Month Change | 12.20% |
| 1 Year Change | 27.78% |
| 3 Year Change | 35.29% |
| 5 Year Change | 24.32% |
| Change since IPO | -91.71% |
Recent News & Updates
Shareholder Returns
| ASC | ZA Pharmaceuticals | ZA Market | |
|---|---|---|---|
| 7D | 0% | -1.1% | 0.4% |
| 1Y | 27.8% | -10.1% | 21.0% |
Return vs Industry: ASC exceeded the ZA Pharmaceuticals industry which returned -9.3% over the past year.
Return vs Market: ASC exceeded the ZA Market which returned 22.3% over the past year.
Price Volatility
| ASC volatility | |
|---|---|
| ASC Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in ZA Market | 10.5% |
| 10% least volatile stocks in ZA Market | 2.7% |
Stable Share Price: ASC has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: ASC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | A. Neethling | www.ascendishealth.com |
Ascendis Health Limited, a health and wellness company, provides health and wellness products and clinical and diagnostic medical devices in South Africa. It operates in Consumer Health and Medical Devices segments. The company offers multivitamins and minerals, micronutrients, and nutraceutical supplements; vitamins and homeopathic and herbal products; and over-the-counter, complementary, alternative consumer, skin, and scripted compounding products under the Solal, Solal Skincare, Chela-Preg, Bettaway, Chela-fer, Jungle-Vites, Vitaforce, and Menacal7 brands.
Ascendis Health Limited Fundamentals Summary
| ASC fundamental statistics | |
|---|---|
| Market cap | R575.69m |
| Earnings (TTM) | R11.28m |
| Revenue (TTM) | n/a |
Is ASC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASC income statement (TTM) | |
|---|---|
| Revenue | R0 |
| Cost of Revenue | R0 |
| Gross Profit | R0 |
| Other Expenses | -R11.28m |
| Earnings | R11.28m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.018 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 16.8% |
How did ASC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/08 15:47 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ascendis Health Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marcelle Jankelow | Investec Bank plc (UK) |